These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 27115337

  • 21. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
    Zhang W, Otsuka T, Sugo N, Ardeshiri A, Alhadid YK, Iliff JJ, DeBarber AE, Koop DR, Alkayed NJ.
    Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
    [Abstract] [Full Text] [Related]

  • 22. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE, Elshenawy OH, Abdelrady M, El-Kadi AO.
    Toxicol Lett; 2014 Apr 07; 226(1):53-62. PubMed ID: 24472606
    [Abstract] [Full Text] [Related]

  • 23. Soluble Epoxide Hydrolase as a Potential Key Factor for Human Prenatal Development.
    Cizkova K, Rajdova A, Ehrmann J.
    Cells Tissues Organs; 2016 Apr 07; 201(4):277-86. PubMed ID: 27144772
    [Abstract] [Full Text] [Related]

  • 24. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR, Jang HS, Salem FE, Ferrer FA, Kim J, Padanilam BJ.
    Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F138-F151. PubMed ID: 36475868
    [Abstract] [Full Text] [Related]

  • 25. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
    Iliff JJ, Wang R, Zeldin DC, Alkayed NJ.
    Am J Physiol Heart Circ Physiol; 2009 May 01; 296(5):H1352-63. PubMed ID: 19304946
    [Abstract] [Full Text] [Related]

  • 26. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat.
    Iliff JJ, Close LN, Selden NR, Alkayed NJ.
    Exp Physiol; 2007 Jul 01; 92(4):653-8. PubMed ID: 17639071
    [Abstract] [Full Text] [Related]

  • 27. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
    Karkhanis A, Tram NDT, Chan ECY.
    Biochem Pharmacol; 2017 Dec 15; 146():188-198. PubMed ID: 28958841
    [Abstract] [Full Text] [Related]

  • 28. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
    Huang H, Weng J, Wang MH.
    Prostaglandins Other Lipid Mediat; 2016 Sep 15; 125():80-9. PubMed ID: 27184755
    [Abstract] [Full Text] [Related]

  • 29. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
    Zhu Y, Blum M, Hoff U, Wesser T, Fechner M, Westphal C, Gürgen D, Catar RA, Philippe A, Wu K, Bubalo G, Rothe M, Weldon SM, Dragun D, Schunck WH.
    PLoS One; 2016 Sep 15; 11(1):e0145645. PubMed ID: 26727266
    [Abstract] [Full Text] [Related]

  • 30. Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.
    Jiang H, Quilley J, Doumad AB, Zhu AG, Falck JR, Hammock BD, Stier CT, Carroll MA.
    Am J Physiol Heart Circ Physiol; 2011 Jun 15; 300(6):H1990-6. PubMed ID: 21398593
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
    Keserü B, Barbosa-Sicard E, Popp R, Fisslthaler B, Dietrich A, Gudermann T, Hammock BD, Falck JR, Weissmann N, Busse R, Fleming I.
    FASEB J; 2008 Dec 15; 22(12):4306-15. PubMed ID: 18725458
    [Abstract] [Full Text] [Related]

  • 33. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
    Deng Y, Edin ML, Theken KN, Schuck RN, Flake GP, Kannon MA, DeGraff LM, Lih FB, Foley J, Bradbury JA, Graves JP, Tomer KB, Falck JR, Zeldin DC, Lee CR.
    FASEB J; 2011 Feb 15; 25(2):703-13. PubMed ID: 21059750
    [Abstract] [Full Text] [Related]

  • 34. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis.
    Zeldin DC, Wei S, Falck JR, Hammock BD, Snapper JR, Capdevila JH.
    Arch Biochem Biophys; 1995 Jan 10; 316(1):443-51. PubMed ID: 7840649
    [Abstract] [Full Text] [Related]

  • 35. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
    Maayah ZH, Abdelhamid G, Elshenawy OH, El-Sherbeni AA, Althurwi HN, McGinn E, Dawood D, Alammari AH, El-Kadi AOS.
    Cardiovasc Toxicol; 2018 Jun 10; 18(3):268-283. PubMed ID: 29196978
    [Abstract] [Full Text] [Related]

  • 36. Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.
    Cizkova K.
    Toxicol Appl Pharmacol; 2018 Sep 15; 355():156-163. PubMed ID: 29960002
    [Abstract] [Full Text] [Related]

  • 37. Soluble epoxide hydrolase disruption as therapeutic target for wound healing.
    Sander AL, Sommer K, Neumayer T, Fleming I, Marzi I, Barker JH, Frank J, Jakob H.
    J Surg Res; 2013 Jun 15; 182(2):362-7. PubMed ID: 23122666
    [Abstract] [Full Text] [Related]

  • 38. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
    Sun D, Cuevas AJ, Gotlinger K, Hwang SH, Hammock BD, Schwartzman ML, Huang A.
    Am J Physiol Heart Circ Physiol; 2014 Apr 15; 306(8):H1146-53. PubMed ID: 24561863
    [Abstract] [Full Text] [Related]

  • 39. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
    Liu L, Puri N, Raffaele M, Schragenheim J, Singh SP, Bradbury JA, Bellner L, Vanella L, Zeldin DC, Cao J, Abraham NG.
    Prostaglandins Other Lipid Mediat; 2018 Sep 15; 138():1-8. PubMed ID: 30041041
    [Abstract] [Full Text] [Related]

  • 40. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
    Chaudhary KR, Zordoky BN, Edin ML, Alsaleh N, El-Kadi AO, Zeldin DC, Seubert JM.
    Prostaglandins Other Lipid Mediat; 2013 Sep 15; 104-105():8-17. PubMed ID: 22922020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.